DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the corresponding author upon reasonable request.

REFERENCES

[1] Harden ME, Munger K. Human papillomavirus molecular biology. MUTAT RES-REV MUTAT. 2017;772:3-12.
[2] Petca A, Borislavschi A, Zvanca ME, et al. Non-sexual HPV transmission and role of vaccination for a better future. EXP THER MED. 2020;20(6):186.
[3] Soheili M, Keyvani, Soheili M, et al. Human papilloma virus: A review study of epidemiology,carcinogenesis,diagnostic methods, and treatment of all HPV-related cancers. Med J Islam Repub Iran. 2021;35:65.
[4] Shapiro SB, Wissing MD, Khosrow-Khavar F, et al. Male Circumcision and Genital Human Papillomavirus (HPV) Infection in Males and Their Female Sexual Partners: Findings from the HPV Infection and Transmission Among Couples Through Heterosexual Activity (HITCH) Cohort Study. J INFECT DIS. 2022;226(7):1184-1194.
[5] de Martel C, Georges D, Bray F, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):180-190.
[6] Forman D, de Martel C, Lacey C J, et al. Global Burden of Human Papillomavirus and Related Diseases. Vaccine. 2012;30 Suppl 5:F12–23.
[7] Hartwig S, Syrjänen S, Dominiak-Felden G, et al. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: A review. BMC Cancer. 2012;12:30.
[8] Tisi G, Salinaro F, Apostoli P, et al. HPV vaccination acceptability in young boys. Annali dell’Istituto Superiore di Sanità. 2013;49(3):286–291.
[9] Sammarco ML, Ucciferri C, Tamburro M, et al. High prevalence of human papillomavirus type 58 in HIV infected men who have sex with men: A pre­liminary report in Central Italy. J Med Virol. 2016;88(5):911-914.
[10] Handisurya A, Rieger A, Bankier A, et al. Human papillomavirus type 26 infection causing multiple invasive squamous cell carcinomas of the fingernails in an AIDS patient under highly active antiretroviral therapy. BRIT J DERMATOL. 2007;157(4):788-794.
[11] Olesen TB, Sand FL, Rasmussen CL, et al. Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis. LANCET ONCOL. 2019;20(1):145-158.
[12] Laura Elst, Maarten Albersen. HPV Vaccination: Does It Have a Role in Preventing Penile Cancer and Other Preneoplastic Lesions? SEMIN ONCOL NURS. 2022;38(3):151284.
[13] Schneede P. Human papillomavirus disease burden in men: HPV prevention is a man’s business. UROLOGE. 2018;57(12):1452-1456.
[14] MCBRIDE A A. Human Papillomaviruses: diversity, infection and host interactions. Nature Rev Microbiol. 2022;20:95-108.
[15] Thomas A, Necchi A, Muneer A, et al. Penile cancer. Nat Rev Dis Primers. 2021;7(1):11.
[16] Spiess PE, Dhillon J, Baumgarten AS, et al. Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies. CA Cancer J Clin. 2016;66(6):481–495.
[17] World Health Organization. Human papillomaviruses; World Health Organization: Lyon, 262 France, (2006).
[18] DOORBAR J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006;110(5):525-541.
[19] WU X, WANG S, LI M, et al. Conditional reprogramming:next generation cell culture. Acta Pharm Sin B. 2020;10(8):1360-1381.
[20] Saunders-Wood T, Egawa N, Zheng K, et al. Role of E6 in Maintaining the Basal Cell Reservoir during Productive Papillomavirus Infection. J VIROL. 2022;96(5):e0118121.
[21] Stone KM, Karem KL, Sternberg MR, et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J INFECT DIS. 2002;186(10):1396-1402.
[22] Peterson LM, Orr JA, Rogelberg SD, et al. Social-contextual factors interact with masculinity to influence college men’s HPV vaccination intentions: The role of descriptive norms, prototypes, and physician gender. J BEHAV MED. 2022;45(6):825-840.
[23] Nemcova J, Riegert J, Cerna K, et al. Prevalence of oral and anal human papillomavirus infection in Czech predominantly Human immunodeficiency virus-positive men having sex with men - data from a previously unreported population. Ondic, O; INT J STD AIDS. 2022;33(12):1054-1064.
[24] Skoulakis A, Fountas S, Mantzana-Peteinelli M, et al. Prevalence of human papillomavirus and subtype distribution in male partners of women with cervical intraepithelial neoplasia (CIN): A systematic review. BMC Infect Dis. 2019;19(1):192.
[25] Lau JT, Wang Z, Lau M, et al. Perceptions of HPV, genital warts, and penile/anal cancer and high-risk sexual behaviors among men who have sex with men in Hong Kong. ARCH SEX BEHAV. 2014;43(4):789-800.
[26] Sudenga SL, Torres BN, Silva R, et al. Comparison of the natural history of genital HPV infection among men by country: Brazil, Mexico, and the United States. Cancer Epidem Biomar. 2017;26(7):1043-1052.
[27] MOREIRA ED, GIULIANO AR, PALEFSKY J, et al. Incidence, clearance, and disease progression of genital human papillomavirus infection in heterosexual men. J Infect Dis. 2014;210(2):192-199.
[28] Li X, Li M, Yang Y, et al. Anal HPV/HIV co-infection among men who have sex with men: A cross-sectional survey from three cities in China. Sci Rep. 2016;6:21368.
[29] Yin W G, Yang M, Peng L, et al. Male papillomavirus infection and genotyp­ing in the Qingyuan area. Virol J. 2020;17(1):155.
[30] Xin H, Li H, Li Z, et al. Genital HPV infection among heterosexual and ho­mosexual male attendees of sexually transmitted diseases clinic in Beijing, China. Epidemiol Infect. 2017;145(13):2838-2847.
[31] Xiaoxiao Li, Fenfen Xiang, Zixi Chen, et al. Genital Human Papillomavirus Prevalence and Genotyping Among Males in Putuo District of Shanghai, China 2015-2019. CLINICAL RESEARCH. 2021;27: e932093.
[32] Shigehara K, Sasagawa T, Kawaguchi S, et al. Prevalence of human papillomavirus infection in the urinary tract of men with urethritis. Int J Urol. 2010;17(6):563-568.
[33] Hoai BN, Cao TN, Luong Thi LA, et al. Human papillomavirus prevalence and genotype distribution in Vietnamese male patients between 2016 and 2020. J MED VIROL. 2022;94(6):2892-2896.
[34] Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis. 2005;191(11):1796-1807.
[35] Finan RR, Chemaitelly H, Racoubian E, et al. Genetic diversity of human papillomavirus (HPV) as specified by the detection method, gender, and year of sampling: a retrospective cross-sectional study. ARCH GYNECOL OBSTET. 2023;307(5):1469-1479.
[36] Bruni L, Diaz M, Castellsagué X, Ferrer E, et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789-1799.
[37] Goldstone SE, Giuliano AR, Palefsky JM, et al. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis. 2022;22(3):413-425.
[38] da Costa Nunes JF, Pires S, Chade DC. Human papillomavirus vaccination and prevention of intraepithelial neoplasia and penile cancer: review article. Curr Opin Urol. 2020;30(2):208-212.
[39] Li-li Zheng, Shuang-feng Chen, Fei Yang, et al. High-risk HPV prevalence and genotype distribution among women in Liaocheng, Shandong Province, China from 2016 to 2022. Front Public Health. 2023;11:1145396.
[40] WHO. Human papillomavirus and related diseases report. 2021(2021-10-22) [2022-06-06]. https:// hpvcentre.net /statistics /reports /X-WX.pdf.
[41] Laseron O, Oliffe JL, Krist J, et al. HPV vaccine and college-age men: a scoping review. Am J Men’s Health. 2020;14 (6):1557988320973826.

Tables